Skip to main content
Clinical Medicine logoLink to Clinical Medicine
. 2012 Dec;12(6):504. doi: 10.7861/clinmedicine.12-6-504

Genomic medicine: challenges and opportunities for physicians

H Burton, Cole T, AM Lucassen
PMCID: PMC5922586

Errors were introduced to Table 1 in this article during typesetting. The ‘Genetically predisposed subgroup’ cell of the breast cancer row should read ‘About 5% of cancers will be largely due to inheritance of a mutation in BRCA1 or BRCA2’, and the ‘Importance of molecular diagnosis in management’ cell of breast cancer should read ‘Further preventive management for breast cancer and/or ovarian cancer (eg mammography or MRI; prophylactic surgery of breasts and /or ovaries)’. The ‘Genetically predisposed subgroup’ cell of the bowel cancer row should read ‘About 5% of all cancers will be due, in large part, to inheritance of a mutated gene: eg familial polyposis, Lynch syndrome or MutYH polyposis’ and the ‘Importance of molecular diagnosis in management’ cell for bowel cancer should read ‘Consideration of other at-risk organs (eg uterus or ovaries in Lynch syndrome)’.

Table 1.

Common conditions and genetically predisposed subgroups.

graphic file with name clinmed-12-6-504tbl1.jpg

The corrected table is printed here.


Articles from Clinical Medicine are provided here courtesy of Royal College of Physicians

RESOURCES